Induction Chemotherapy with Paclitaxel Liposome, Nedaplatin, and Fluorouracil in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Phase II Study
第一作者单位:[1]Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China[2]Nanjing Univ, Clin Canc Inst, Nanjing, Jiangsu, Peoples R China
推荐引用方式(GB/T 7714):
Yan J.,Yang J.,Ren W.,et al.Induction Chemotherapy with Paclitaxel Liposome, Nedaplatin, and Fluorouracil in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Phase II Study[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2018,102(3):E374-E375.doi:10.1016/j.ijrobp.2018.07.1118.
APA:
Yan, J.,Yang, J.,Ren, W.,Wang, K.,Huang, B....&Liu, B..(2018).Induction Chemotherapy with Paclitaxel Liposome, Nedaplatin, and Fluorouracil in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Phase II Study.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,102,(3)
MLA:
Yan, J.,et al."Induction Chemotherapy with Paclitaxel Liposome, Nedaplatin, and Fluorouracil in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Phase II Study".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 102..3(2018):E374-E375